
₹2,49,600(1,200 Shares)
Minimum Investment
IPO Dates
Jun 18, 2026 – Jun 22, 2026
Price Band
₹196–208 per equity share
Lot Size
600
Listing
Jun 25, 2026
Listing At
NSE SME
NII Sub-Categories
bHNI (> ₹10L)
Bids above ₹10L
sHNI (< ₹10L)
Bids ₹2L to ₹10L
Overall Subscription
Total Bids Received
385.33x
Shares Offered
2,07,000
Shares Offered
2,73,600
Shares Offered
4,09,800
Shares Offered
4,81,200
Shares Offered
82,200
Incorporatedin June 2024, Avience Biomedicals Limited is an ISO-certified company involved in the manufacture, supply, and export of molecular diagnostics solutions, with an emphasis on biotechnology,...
EPS (Pre-IPO)
17.94
EPS (Post-IPO)
12.56
P/E (Pre-IPO)
11.59
P/E (Post-IPO)
16.56
RoNW
22.38%
P/B Value
2.94
Market Cap
₹114.09 Cr.
* All figures are in ₹ Crores unless otherwise stated.
C-11, Block-C, Community Centre, Janakpuri A-3, New Delhi - 110058.
Skyline Financial Services Private Ltd
The Avience Biomedicals Limited IPO price band is set at ₹196.00 to ₹208.00 per equity share.
The lot size for Avience Biomedicals Limited IPO is 600 shares per lot. The minimum investment amount is approximately ₹1,24,800.
The Avience Biomedicals Limited IPO opens on Jun 18, 2026 and closes on Jun 22, 2026.
Avience Biomedicals Limited IPO is expected to be listed on Jun 25, 2026 on NSE SME.
The current GMP for Avience Biomedicals Limited IPO is ₹100, suggesting an expected listing price of around ₹296.00. Note: GMP is an unofficial market indicator.
The registrar for Avience Biomedicals Limited IPO is Skyline Financial Services Private Ltd. You can contact them at ipo@skylinerta.com.